182 related articles for article (PubMed ID: 12842431)
1. Expression of dystrophin driven by the 1.35-kb MCK promoter ameliorates muscular dystrophy in fast, but not in slow muscles of transgenic mdx mice.
Dunant P; Larochelle N; Thirion C; Stucka R; Ursu D; Petrof BJ; Wolf E; Lochmüller H
Mol Ther; 2003 Jul; 8(1):80-9. PubMed ID: 12842431
[TBL] [Abstract][Full Text] [Related]
2. [Gene therapy for muscular dystrophy].
Takeda S
No To Hattatsu; 2004 Mar; 36(2):117-23. PubMed ID: 15031985
[TBL] [Abstract][Full Text] [Related]
3. Micro-dystrophin cDNA ameliorates dystrophic phenotypes when introduced into mdx mice as a transgene.
Sakamoto M; Yuasa K; Yoshimura M; Yokota T; Ikemoto T; Suzuki M; Dickson G; Miyagoe-Suzuki Y; Takeda S
Biochem Biophys Res Commun; 2002 May; 293(4):1265-72. PubMed ID: 12054513
[TBL] [Abstract][Full Text] [Related]
4. Dystrophin-negative slow-twitch soleus muscles are not susceptible to eccentric contraction induced injury over the lifespan of the
Kiriaev L; Kueh S; Morley JW; Houweling PJ; Chan S; North KN; Head SI
Am J Physiol Cell Physiol; 2021 Oct; 321(4):C704-C720. PubMed ID: 34432537
[TBL] [Abstract][Full Text] [Related]
5. The short MCK1350 promoter/enhancer allows for sufficient dystrophin expression in skeletal muscles of mdx mice.
Larochelle N; Oualikene W; Dunant P; Massie B; Karpati G; Nalbantoglu J; Lochmuller H
Biochem Biophys Res Commun; 2002 Apr; 292(3):626-31. PubMed ID: 11922612
[TBL] [Abstract][Full Text] [Related]
6. Construction and analysis of compact muscle-specific promoters for AAV vectors.
Wang B; Li J; Fu FH; Chen C; Zhu X; Zhou L; Jiang X; Xiao X
Gene Ther; 2008 Nov; 15(22):1489-99. PubMed ID: 18563184
[TBL] [Abstract][Full Text] [Related]
7. Osteoprotegerin and β
Dufresne SS; Boulanger-Piette A; Frenette J
Am J Pathol; 2017 Mar; 187(3):498-504. PubMed ID: 28041995
[TBL] [Abstract][Full Text] [Related]
8. Efficiency and functional consequences of adenovirus-mediated in vivo gene transfer to normal and dystrophic (mdx) mouse diaphragm.
Petrof BJ; Acsadi G; Jani A; Massie B; Bourdon J; Matusiewicz N; Yang L; Lochmüller H; Karpati G
Am J Respir Cell Mol Biol; 1995 Nov; 13(5):508-17. PubMed ID: 7576685
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of myosin heavy chain isoforms in the masticatory muscles of dystrophin-deficient mice.
Spassov A; Gredes T; Gedrange T; Lucke S; Morgenstern S; Pavlovic D; Kunert-Keil C
Eur J Orthod; 2011 Dec; 33(6):613-9. PubMed ID: 21187529
[TBL] [Abstract][Full Text] [Related]
10. Efficient muscle-specific transgene expression after adenovirus-mediated gene transfer in mice using a 1.35 kb muscle creatine kinase promoter/enhancer.
Larochelle N; Lochmüller H; Zhao J; Jani A; Hallauer P; Hastings KE; Massie B; Prescott S; Petrof BJ; Karpati G; Nalbantoglu J
Gene Ther; 1997 May; 4(5):465-72. PubMed ID: 9274724
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity.
Cox GA; Cole NM; Matsumura K; Phelps SF; Hauschka SD; Campbell KP; Faulkner JA; Chamberlain JS
Nature; 1993 Aug; 364(6439):725-9. PubMed ID: 8355788
[TBL] [Abstract][Full Text] [Related]
12. Improved adenoviral vectors for gene therapy of Duchenne muscular dystrophy.
Hauser MA; Amalfitano A; Kumar-Singh R; Hauschka SD; Chamberlain JS
Neuromuscul Disord; 1997 Jul; 7(5):277-83. PubMed ID: 9267841
[TBL] [Abstract][Full Text] [Related]
13. Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.
Burkin DJ; Wallace GQ; Nicol KJ; Kaufman DJ; Kaufman SJ
J Cell Biol; 2001 Mar; 152(6):1207-18. PubMed ID: 11257121
[TBL] [Abstract][Full Text] [Related]
14. CTLA4Ig delivered by high-capacity adenoviral vector induces stable expression of dystrophin in mdx mouse muscle.
Jiang Z; Schiedner G; Gilchrist SC; Kochanek S; Clemens PR
Gene Ther; 2004 Oct; 11(19):1453-61. PubMed ID: 15269713
[TBL] [Abstract][Full Text] [Related]
15. Dystrophin involved in the susceptibility of slow muscles to hindlimb unloading via concomitant activation of TGF-β1/Smad3 signaling and ubiquitin-proteasome degradation in mice.
Zhang P; Li W; Liu H; Li J; Wang J; Li Y; Chen X; Yang Z; Fan M
Cell Biochem Biophys; 2014 Nov; 70(2):1057-67. PubMed ID: 24839113
[TBL] [Abstract][Full Text] [Related]
16. Voltage-gated sodium channel (SkM1) content in dystrophin-deficient muscle.
Ribaux P; Bleicher F; Couble ML; Amsellem J; Cohen SA; Berthier C; Blaineau S
Pflugers Arch; 2001 Mar; 441(6):746-55. PubMed ID: 11316257
[TBL] [Abstract][Full Text] [Related]
17. Rescue of dystrophic skeletal muscle by PGC-1α involves a fast to slow fiber type shift in the mdx mouse.
Selsby JT; Morine KJ; Pendrak K; Barton ER; Sweeney HL
PLoS One; 2012; 7(1):e30063. PubMed ID: 22253880
[TBL] [Abstract][Full Text] [Related]
18. Power output of fast and slow skeletal muscles of mdx (dystrophic) and control mice after clenbuterol treatment.
Lynch GS; Hinkle RT; Faulkner JA
Exp Physiol; 2000 May; 85(3):295-9. PubMed ID: 10825417
[TBL] [Abstract][Full Text] [Related]
19. Mdx transgenic mouse: restoration of recombinant dystrophin to the dystrophic muscle.
Lee CC; Pons F; Jones PG; Bies RD; Schlang AM; Leger JJ; Caskey CT
Hum Gene Ther; 1993 Jun; 4(3):273-81. PubMed ID: 8338875
[TBL] [Abstract][Full Text] [Related]
20. Functional protection of dystrophic mouse (mdx) muscles after adenovirus-mediated transfer of a dystrophin minigene.
Deconinck N; Ragot T; Maréchal G; Perricaudet M; Gillis JM
Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3570-4. PubMed ID: 8622977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
